Eshoo: Foreign Drug Manufacturing Will Be Top-Line Priority In 2020

By Beth Wang / December 19, 2019 at 2:41 PM
Leading lawmakers on the House Energy & Commerce Committee pegged the United States’ reliance on foreign manufacturing of generic drugs as a top-line issue they will tackle in 2020. Lawmakers called out FDA, saying the agency has failed to fully protect the nation’s drug supply, and said manufacturing needs to be brought back to the United States. E&C Chair Frank Pallone (D-NJ) also listed his youth e-cigarette legislation among the bills he hopes to get to the House floor early...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.